Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2003
10/09/2003CA2480888A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003CA2480869A1 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003CA2480638A1 Substituted benzazoles and use thereof as raf kinase inhibitors
10/09/2003CA2480358A1 Crystalline forms of rabeprazole sodium
10/09/2003CA2480352A1 Lansoprazole polymorphs and processes for preparation thereof
10/09/2003CA2479930A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
10/09/2003CA2479764A1 Hemiasterlin derivatives and uses thereof
10/09/2003CA2479744A1 Substituted 2,3-diphenyl pyridines
10/09/2003CA2479618A1 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003CA2479453A1 Use of benzimidazole analogs in the treatment of cell proliferation
10/08/2003EP1349856A2 Isoindolin-1-one glucokinase activators
10/08/2003EP1349852A2 4-(hetero)aryl substituted indolinones
10/08/2003EP1349851A1 Compounds
10/08/2003EP1349850A1 Sodium channel modulators derived from 2-piperidylimidazoles
10/08/2003EP1349849A1 Microbiocidal n-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives
10/08/2003EP1349848A2 Aryloxy piperidinyl indoles for treating depression
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349833A1 Indole and dihydroindole derivatives
10/08/2003EP1349535A2 Indole/indoline based hybrid dyes and indole/indoline based hybrid dye intermediate products
10/08/2003EP1171437B1 Pesticidal indazole or benzotriazole derivatives
10/08/2003EP1105377B1 Pyrimidinone derivatives for the treatment of atherosclerosis
10/08/2003EP0946512B1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/08/2003EP0927170B1 Piperazino derivatives as neurokinin antagonists
10/08/2003EP0923556B1 An asymmetric conjugate addition reaction
10/08/2003CN1447841A Organic compouns
10/08/2003CN1447806A 4-,5-,6-and 7-indole derivatives useful for treatment of CNS disorders
10/08/2003CN1447805A Novel indole derivatives and their use as medicaments
10/08/2003CN1447794A Novel compounds
10/08/2003CN1447693A Use of angiotensin Ôàí antagonists
10/08/2003CN1446813A Novel dihydric indole compound, their prepn. process and medicinal compsns. contg.them
10/08/2003CN1446812A Acid-addition salt of hexahydropyridine compound having optical activity, and its prepn. process
10/08/2003CN1123571C 1-(3-heteroarylpropyl-or-prop-2-enyl)-4-benzylpiperidines used as NMDA receptor antagonists
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/07/2003US6630590 Producing a carbostyril derivative represented by the following general formula (I):by reaction of with a tetrazole derivative represented by the following general formula (III): wherein X represents a halogen atom, and A and R are as
10/07/2003US6630589 Screening assays for compounds that are potentially useful for treating or preventing a proliferative disease. The assays are based on contacting a candidate compound with a cell containing a nucleic acid including a HER2 regulatory element
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630499 Control of arthropods in animals
10/07/2003US6630496 Inhibitors of phospholipase enzymes
10/07/2003US6630495 Compound containing 2-pyridyl or its N-oxide
10/07/2003US6630494 Treatment for central degenerative disorders, brain power disorders, depressions, and for prophylaxis of cerebral circulatory disorders
10/07/2003US6630493 Heterocyclically substituted amides, their preparation and use
10/07/2003US6630491 Use of nicotinic analogs for treatment of degenerative diseases of the nervous system
10/07/2003US6630489 Quinoline derivatives as tyrosine kinase inhibitors
10/07/2003US6630481 Phototherapeutic and catalytic photoactivated DNA cleaving agents
10/07/2003US6630479 Methods and compositions utilizing quinazolinones
10/07/2003US6630469 5-HT7 receptor antagonists
10/07/2003US6630468 Disubstituted pyrazolines and triazolines as factor Xa inhibitors
10/07/2003US6630463 Heterocycle-containing carboxylic acid derivative and drug containing the same
10/07/2003CA2302436C Branched alkoxy-substituted 2-aminopyridines
10/07/2003CA2287552C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/07/2003CA2263957C Diarylmethyl piperazine derivatives as delta opioid agonists
10/07/2003CA2107105C Heterocyclic-cyclic amine derivatives
10/02/2003WO2003080760A1 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
10/02/2003WO2003080597A1 Method for manufacture of sertindole
10/02/2003WO2003080596A2 Bicyclic fused pyridinyl amides and advantageous compositions thereof for use as fungicides
10/02/2003WO2003080585A1 Novel aminobenzamide derivative
10/02/2003WO2003080582A2 Fredericamycin derivatives
10/02/2003WO2003080581A1 Phenanthridinones as parp inhibitors
10/02/2003WO2003080580A2 Quinoline derivatives and their use as 5-ht6 ligands
10/02/2003WO2003080579A1 Novel adamantane derivatives
10/02/2003WO2003080578A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
10/02/2003WO2003080577A2 Amidoacetonitrile compounds
10/02/2003WO2003080574A1 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
10/02/2003WO2003080573A1 Phthalimido derivatives as inhibitors of monoamine oxidase b
10/02/2003WO2003080564A1 Menthol substituted antithrombotic pai-1 inhibitors
10/02/2003WO2003080184A1 1,2-dihydropyrazol-3-ones as cytokine mediators
10/02/2003WO2003080060A1 Substituted piperazine antithrombotic pai-1 inhibitors
10/02/2003WO2003080058A1 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/02/2003WO2003080054A1 Use of pyridyl amides as inhibitors of angiogenesis
10/02/2003WO2003080050A1 The use of 3-[1-[2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl]-3,6-dihydro-2h-pyridin-4-yl]-6-chloro-1h-indole or its enantiomers for the treatment of diseases and disorders responsive to 5-ht (serotonin) re-uptake inhibition
10/02/2003WO2003079986A2 Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases
10/02/2003WO2003079984A2 Substituted tetracycline compounds
10/02/2003WO2003079973A2 Mitotic kinesin inhibitors
10/02/2003WO2003079787A1 Synergistic fungicide compositions containing at least one n-`(2-pyridinyl)methyl!-3-pyridinecarboxamide derivative and one or more further fungicides useful for controlling fungal plant diseases
10/02/2003WO2003064385A3 Delta1-pyrrolines and their use as pest control agents
10/02/2003WO2003053358A3 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
10/02/2003WO2003045912A8 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
10/02/2003WO2003042173A8 Nk1 antagonists
10/02/2003WO2003010160A3 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists
10/02/2003WO2003002107A3 Use of tyrosine kinase inhibitors for treating multiple sclerosis (ms)
10/02/2003WO2002048139A3 Oxazolidinone photoaffinity probes
10/02/2003WO2002008193A3 Therapeutic acridone and acridine compounds
10/02/2003US20030187270 Therapy for nicotine dependency
10/02/2003US20030187268 Imidazole derivatives
10/02/2003US20030187266 Non-nucleoside reverse transcriptase inhibitors
10/02/2003US20030187258 Bactericides
10/02/2003US20030187255 Therapeutic heterocycles
10/02/2003US20030187254 Anticholesterol agents; cardiovascular disorders; dietetics; antidiabetic agents
10/02/2003US20030187060 Aminoalkenylbenzoyl-benzofuran or benzothiophene, method for preparing same and compositions containing same
10/02/2003US20030187053 Eating disorders; antilipemic agents; anticholesterol agents; cardiovascular disorders
10/02/2003US20030187031 Antiinflammatory agents; autoimmune disease; rheumatic disorders
10/02/2003US20030187026 Antiproliferative agents
10/02/2003US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders
10/02/2003US20030187023 Sulfone derivatives, process for their production and use thereof
10/02/2003US20030187022 Pain management; analgesics
10/02/2003US20030187020 Chemical compounds
10/02/2003US20030187009 Analgesics, diarrhea, anticonvulsants, antitussive agents or drug abuse therapy
10/02/2003US20030187008 Quinolonecarboxylic acid derivative
1 ... 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 ... 1080